Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells
Patrizia Malkomes(Goethe University Frankfurt), Michael A. Rieger(Goethe University Frankfurt)
Cited by 33
Related Papers
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
|Nature Communications|2024|71
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
|Oncogene|2021|40